scholarly journals Primary hepatic gastrinoma being diagnosed preoperatively: a case report and literature review

2020 ◽  
Vol 6 (1) ◽  
Author(s):  
Shunya Hanzawa ◽  
Hiroshi Sadamori ◽  
Masaaki Kagoura ◽  
Kazuteru Monden ◽  
Masayoshi Hioki ◽  
...  

Abstract Background A majority of gastrinomas causing Zollinger–Ellison syndrome are located in the duodenum or pancreas. Primary hepatic gastrinomas are rare and difficult to diagnose. We report a rare case of primary hepatic gastrinoma, which could be diagnosed preoperatively. Case presentation A 29-year-old man with a 55-mm tumor in segments 5 and 6 (S 5/6) of the liver was admitted to our hospital. After thorough investigations, he was treated for a suspected inflammatory pseudotumor and advised to undergo routine follow-up. Two years later, he revisited our hospital with a complaint of abdominal pain, vomiting, and diarrhea. Upper gastrointestinal endoscopy revealed multiple duodenal ulcers. His serum gastrin level was 2350 pg/mL (normal: 37–172 pg/mL), suggesting Zollinger–Ellison syndrome. Abdominal computed tomography showed a 78-mm hypervascular tumor with cystic degeneration in the S 5/6 region of the liver, with a potential to increase over time. The tumor showed hypointensity on T2-weighted and hyperintensity on diffusion-weighted abdominal contrast-enhanced magnetic resonance imaging. Somatostatin receptor scintigraphy (SRS) only detected a hepatic tumor. No tumors in the gastrinoma triangle were detected by endoscopic ultrasonography. Hence, selective arterial calcium injection (SACI) test was performed to determine the location of the gastrinoma. The serum gastrin concentration increased from 4620 pg/mL to 23,600 pg/mL at 20 s after calcium gluconate injection into the proper hepatic artery. Conversely, no effect on serum gastrin level was observed after the injection into any other arteries. Extended right hepatic lobectomy and cholecystectomy were performed after percutaneous transhepatic portal vein embolization. A histopathological examination of the liver tumor revealed a gastrinoma. The patient’s serum gastrin concentration on postoperative day 1 decreased to 65 pg/mL. Conclusion We report a surgical case of primary hepatic gastrinoma correctly diagnosed preoperatively. The patient underwent extended right hepatic lobectomy, resulting in a histological definitive diagnosis of primary hepatic gastrinoma.

2016 ◽  
Vol 8 (1) ◽  
pp. 55-127
Author(s):  
Hideaki Oe ◽  
Ryuichiro Doi

ABSTRACT BACKGROUND AND AIMS Gastrointestinal and pancreatic neuroendocrine tumors (NET) are classified as low grade (G1), intermediate grade (G2), and high grade (G3) by mitotic rate and/or Ki-67 index. The basic treatment for neuroendocrine carcinoma (NEC, G3) with remote metastasis is platinum-based systemic chemotherapy. In contrast, for patients with NET G1 or G2 with remote metastasis, multidisciplinary treatment is necessary in order to prolong patients' survival and relieve symptoms. We report here a patient with pancreatic G1 gastrinoma and its multiple liver metastases. METHODS The patient was a 42 years old male who had been suffering from diarrhea for 2 years, and his serum level of gastrin was as high as 4200 pg/mL before treatment. Needle biopsy of the liver proved the tumor was positive for chromogranin A, gastrin, and somatostatin receptor type 2A. RESULTS First, we chose an induction drug therapy with sunitinib and octreotide. The size of the liver tumors decreased dramatically and the serum gastrin level became lower than 500 pg/mL. About 1 year after diagnosis, we performed distal pancreatectomy and right hepatic lobectomy. After surgery, the serum gastrin level was normalized, and the activity of daily living (ADL) of the patient was much improved by the consecutive therapies. During the 2-year postoperative follow-up time, the course was favorable and no recurrent lesion was found. CONCLUSION Even when there are remote metastases, multidisciplinary treatment including surgical resection should be considered for G1/ G2 NET. Further, it should be necessary to study in a larger number of patients if perioperative drug therapy for G1/G2 NET with remote metastases is effective.


2021 ◽  
Vol 116 (1) ◽  
pp. S1267-S1267
Author(s):  
Ann Saliares ◽  
Veena Janardan ◽  
Fadi Hawa ◽  
Naresh Gunaratnam

1973 ◽  
Vol 8 (1) ◽  
pp. 91-91
Author(s):  
T. Ishikawa ◽  
H. Itakura ◽  
T. Kitamura ◽  
Y. Muto ◽  
H. Mori ◽  
...  

1980 ◽  
Vol 17 (2) ◽  
pp. 177-186 ◽  
Author(s):  
R. P. Happé ◽  
I. Van Der Gaag ◽  
C.B.H.W. Lamers ◽  
J. Van Toorenburg ◽  
J. F. Rehfeld ◽  
...  

The main clinical signs of three dogs with Zollinger-Ellison syndrome were vomiting, diarrhoea, poor appetite and weight loss. The diagnosis was confirmed by histological examination and by gastrin immunocytochemistry. Gastrin was extracted from pancreatic tumours of two dogs. Gastrin-component III predominated in one dog while gastrin-compo-nent II and gastrin-component III were demonstrated in almost equal amounts in the other dog. In one dog serum gastrin concentration was high. Postmortem examination revealed pancreatic tumours in all three dogs and metastases in the regional lymph nodes and liver in two. The pancreatic tumours contained three patterns of growth: solid, trabecular and acinar. Electron microscopy of liver metastases showed cells with secretory granules. In all three dogs there was an erosive oesophagitis and thick gastric mucosa caused mainly by glandular proliferation. Two dogs had erosions and ulcers in the duodenum, one also in the first part of the jejunum. Villous atrophy and cellular infiltration of the duodenal mucosa were found in all dogs.


Life Sciences ◽  
1994 ◽  
Vol 55 (4) ◽  
pp. 317-325 ◽  
Author(s):  
V. Barrios ◽  
M.J.M. Urrutia ◽  
M. Hernández ◽  
R. Lama ◽  
M.D. García-Nuvo ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document